Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Clinical trial NCT03940196 · COMPLETED
Trial details
- NCT number
- NCT03940196
- Sponsor
- NovoCure Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2023-05-18
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.